Potassium Iodide Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 477.17 Million
CAGR (2026-2031)	4.89%
Fastest Growing Segment	Pharmaceutical
Largest Market	Asia Pacific
Market Size (2031)	USD 635.44 Million

Market Overview

The Global Potassium Iodide Market is projected to grow from USD 477.17 Million in 2025 to USD 635.44 Million by 2031 at a 4.89% CAGR. Potassium iodide is a stable metal-halide salt comprising potassium and iodine, widely utilized in pharmaceutical formulations, nutritional fortification, and industrial applications. The global market is primarily propelled by widespread government mandates for universal salt iodization aimed at preventing thyroid-related disorders and the critical inclusion of the compound in nuclear safety protocols for radiation protection. Furthermore, the expanding requirement for iodine supplementation in animal feed and dietary products continues to support steady commercial demand.

According to the Iodine Global Network, in 2024, effective fortification strategies successfully reduced the number of iodine-deficient countries in the World Health Organization European Region to just two, highlighting the sustained necessity for these products. Despite this progress, the market faces a significant challenge regarding the volatility of raw material prices, as global iodine production is heavily concentrated in limited geographic regions, leaving the supply chain vulnerable to fluctuations and potential disruptions.

Key Market Drivers

Strategic Stockpiling for Nuclear Radiation Emergencies acts as a primary catalyst for the Global Potassium Iodide Market, driven by heightened geopolitical tensions and rigorous safety updates. Governments and health authorities are actively securing stable iodine supplies to protect populations from radioactive exposure. This proactive procurement is evident in local initiatives where agencies ensure readiness through direct distribution. According to the Windsor-Essex County Health Unit, September 2024, in the 'Nuclear Preparedness Program Information Report', the agency distributed approximately 1,300 potassium iodide pill kits to residents within the zones of nuclear installations. Such localized distribution efforts underscore the critical role of potassium iodide in public health strategies, sustaining consistent demand for tablet formulations.

The Rising Prevalence of Thyroid Disorders and Iodine Deficiency further anchors market growth, as potassium iodide remains a frontline therapeutic agent for managing thyroid health. The compound is essential for treating conditions like hyperthyroidism, necessitating high purity pharmaceutical grade production. According to the American Cancer Society, January 2024, in the 'Cancer Facts & Figures 2024' report, it was estimated that there would be approximately 43,720 new cases of thyroid cancer diagnosed in the United States alone for the year. To meet this escalating consumption across medical and industrial sectors, producers are expanding capacity. According to Iofina plc, in January 2025, the company announced a record annual iodine production of 634.1 metric tonnes for 2024, representing a 13.4% increase over the previous year to address the robust global requirement.

Download Free Sample Report

Key Market Challenges

The volatility of raw material prices, resulting from the heavy geographic concentration of global iodine production, acts as a primary destabilizing force that restricts the growth of the potassium iodide market. Manufacturers rely heavily on a steady stream of crude iodine to produce potassium iodide; however, because the upstream supply is centralized in very few regions, the supply chain lacks the elasticity required to absorb shocks. Any disruption in these key extraction zones—whether due to logistical bottlenecks, regulatory changes, or environmental issues—triggers immediate supply shortages and sharp cost increases. This unpredictability prevents potassium iodide producers from securing stable, long-term pricing contracts with pharmaceutical and industrial clients, thereby reducing profit margins and deterring necessary capital investments.

This structural vulnerability is evidenced by recent production data. According to the U.S. Geological Survey, in 2025, Chile accounted for approximately two-thirds of world iodine production in 2024. Such intense market consolidation means that the global potassium iodide sector essentially operates without a geographic safety net. Consequently, the inability to diversify supply sources forces downstream buyers to operate cautiously, limiting inventory expansion and hampering the industry's ability to meet rising demand in critical sectors like nuclear safety and nutrition.

Key Market Trends

The Synergistic Application in Nylon 6,6 Heat Stabilization is propelling the market as manufacturers utilize potassium iodide and copper salts to prevent thermal oxidation in polyamide components. This chemical interaction is essential for maintaining material integrity in high-temperature vehicle environments, making it a critical input for the automotive sector's shift toward lightweight engineering plastics. This industrial application relies heavily on the robust performance of global vehicle manufacturing. According to the European Automobile Manufacturers’ Association (ACEA), March 2025, in the 'Economic and Market Report: Global and EU auto industry – Full year 2024', global passenger car manufacturing totalled 75.5 million units in 2024, sustaining consistent demand for these specialized heat-stabilized formulations.

Simultaneously, the Emergence of Clean Label Iodine Nutraceuticals is reshaping consumption patterns as consumers increasingly prioritize transparent, allergen-free dietary supplements. This shift drives the production of pharmaceutical-grade potassium iodide, which serves as a preferred, stable source of iodine for thyroid health and metabolic support in "clean label" product lines. The commercial expansion of this segment is evidenced by the financial performance of upstream producers who are scaling their derivative output to meet nutritional requirements. According to Iofina plc, September 2025, in the 'Interim Results' statement, the company reported that sales of its iodine derivatives rose by 16% to $9.2 million, reflecting the strengthening market appetite for specialized iodine-based formulations.

Segmental Insights

The Pharmaceutical segment is currently emerging as the fastest-growing category in the Global Potassium Iodide Market, driven by the rising global burden of thyroid disorders and the critical need for effective hormonal treatments. This growth is further amplified by the essential role of potassium iodide in nuclear emergency preparedness, where regulatory bodies like the U.S. Food and Drug Administration (FDA) emphasize its stockpiling for thyroid protection during radiological events. Additionally, the continuous demand for therapeutic solutions to combat iodine deficiency supports this upward trajectory, positioning the Pharmaceutical segment as the primary engine of expansion within the market.

Regional Insights

Asia Pacific leads the Global Potassium Iodide Market, driven primarily by the expansive pharmaceutical manufacturing sectors in China and India. Manufacturers in these nations extensively utilize the compound for therapeutic applications, including thyroid protection agents and expectorants. The region’s market dominance is further reinforced by its robust electronics industry, where potassium iodide is essential for producing optical polarizing films used in Liquid Crystal Displays (LCDs). Additionally, the agricultural sector sustains demand through the widespread adoption of the compound as a vital additive in animal feed to prevent iodine deficiency.

Recent Developments

In January 2025, Iofina plc released a corporate update announcing that it had achieved a record production of 634.1 metric tonnes of crystalline iodine for the 2024 financial year. The company, a specialist in the exploration and production of iodine and iodine-based chemical derivatives, reported that sales of its derivative products, which include potassium iodide, increased significantly during the period. The update also confirmed that the company’s new IO10 plant had reached full operational capacity in late 2024, further strengthening its position in the supply chain for essential iodine compounds used in pharmaceutical and industrial sectors.
In May 2024, G.L. Pharma UK Limited was awarded a contract by the UK Health Security Agency for the supply of potassium iodide tablets. This procurement was executed under a specific dynamic purchasing system dedicated to the provision of antidotes and antibiotics for public health security. The agreement ensures the availability of these essential pharmaceutical countermeasures for the Authority and associated National Health Service bodies across the United Kingdom. The contract reinforces the government's strategy to maintain adequate stockpiles of thyroid-blocking agents to protect the population in the event of a radiological incident.
In April 2024, Anbex, Inc. was awarded a competitive bid by the Department of Health in Hong Kong to supply 187,040 tablets of IOSAT, a potassium iodide product approved for thyroid blocking in radiation emergencies. This contract marked a continued collaboration between the company and the Hong Kong health authorities, following a similar award secured in 2021. The tablets, which are manufactured through a partnership with Deseret Labs, are intended to support the region's emergency preparedness stockpiles. The company also indicated ongoing tender activities to supply similar potassium iodide products to other nations, including Mexico and Brazil.
In April 2024, Toho Earthtech, Inc. commenced operations at its newly expanded manufacturing facility in Nishikawa, Niigata City, Japan. This strategic expansion was designed to significantly scale up the production of water-dissolved natural gas and iodine, which serves as the critical raw material for the global potassium iodide market. The operational enhancement allows the company to meet the growing industrial and pharmaceutical demand for iodine and its derivatives. By increasing its domestic production capacity, the company aims to stabilize the supply chain for essential iodine-based compounds used in various applications, including medical treatments and nutritional supplements.

Key Market Players

Adani Pharmachem P. Ltd.
Nantong Lingang Chemical Co., Ltd.
ZH Chemicals Pvt Ltd
Infinium Pharmachem Pvt.
Ascent Pharmaceuticals, Inc.
HTKP INDUSTRIES PVT LTD
Eskay iodine private limited
Shandong Boyuan Pharmaceutical Co., Ltd.
SAMRAT REMEDIES LTD
Toyota Tsusho America Inc

By Sales Channel	By End Use	By Region
Direct Indirect	Pharmaceutical Food Additives Industrial Laboratory & Analytical Uses Water Treatment & Disinfection Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Potassium Iodide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Potassium Iodide Market, By Sales Channel:

Direct
Indirect

Potassium Iodide Market, By End Use:

Pharmaceutical
Food Additives
Industrial
Laboratory & Analytical Uses
Water Treatment & Disinfection
Others

Potassium Iodide Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Potassium Iodide Market.

Available Customizations:

Global Potassium Iodide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Potassium Iodide Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Potassium Iodide Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Sales Channel (Direct, Indirect)

5.2.2. By End Use (Pharmaceutical, Food Additives, Industrial, Laboratory & Analytical Uses, Water Treatment & Disinfection, Others)

5.2.3. By Region

5.2.4. By Company (2025)

5.3. Market Map

6. North America Potassium Iodide Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Sales Channel

6.2.2. By End Use

6.2.3. By Country

6.3. North America: Country Analysis

6.3.1. United States Potassium Iodide Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Sales Channel

6.3.1.2.2. By End Use

6.3.2. Canada Potassium Iodide Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Sales Channel

6.3.2.2.2. By End Use

6.3.3. Mexico Potassium Iodide Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Sales Channel

6.3.3.2.2. By End Use

7. Europe Potassium Iodide Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Sales Channel

7.2.2. By End Use

7.2.3. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Potassium Iodide Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Sales Channel

7.3.1.2.2. By End Use

7.3.2. France Potassium Iodide Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Sales Channel

7.3.2.2.2. By End Use

7.3.3. United Kingdom Potassium Iodide Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Sales Channel

7.3.3.2.2. By End Use

7.3.4. Italy Potassium Iodide Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Sales Channel

7.3.4.2.2. By End Use

7.3.5. Spain Potassium Iodide Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Sales Channel

7.3.5.2.2. By End Use

8. Asia Pacific Potassium Iodide Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Sales Channel

8.2.2. By End Use

8.2.3. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Potassium Iodide Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Sales Channel

8.3.1.2.2. By End Use

8.3.2. India Potassium Iodide Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Sales Channel

8.3.2.2.2. By End Use

8.3.3. Japan Potassium Iodide Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Sales Channel

8.3.3.2.2. By End Use

8.3.4. South Korea Potassium Iodide Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Sales Channel

8.3.4.2.2. By End Use

8.3.5. Australia Potassium Iodide Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Sales Channel

8.3.5.2.2. By End Use

9. Middle East & Africa Potassium Iodide Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Sales Channel

9.2.2. By End Use

9.2.3. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Potassium Iodide Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Sales Channel

9.3.1.2.2. By End Use

9.3.2. UAE Potassium Iodide Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Sales Channel

9.3.2.2.2. By End Use

9.3.3. South Africa Potassium Iodide Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Sales Channel

9.3.3.2.2. By End Use

10. South America Potassium Iodide Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Sales Channel

10.2.2. By End Use

10.2.3. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Potassium Iodide Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Sales Channel

10.3.1.2.2. By End Use

10.3.2. Colombia Potassium Iodide Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Sales Channel

10.3.2.2.2. By End Use

10.3.3. Argentina Potassium Iodide Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Sales Channel

10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Potassium Iodide Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Adani Pharmachem P. Ltd.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Nantong Lingang Chemical Co., Ltd.

15.3. ZH Chemicals Pvt Ltd

15.4. Infinium Pharmachem Pvt.

15.5. Ascent Pharmaceuticals, Inc.

15.6. HTKP INDUSTRIES PVT LTD

15.7. Eskay iodine private limited

15.8. Shandong Boyuan Pharmaceutical Co., Ltd.

15.9. SAMRAT REMEDIES LTD

15.10. Toyota Tsusho America Inc

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Potassium Iodide Market in 2025?

Which is the dominating region in the Global Potassium Iodide Market?

Which is the fastest growing segment in the Global Potassium Iodide Market?

What is the expected growth rate of the Global Potassium Iodide Market?